The FCS 2024 Annual Report has received an Award of Distinction in The 31st Annual Communicator Awards of the Academy of Interactive & Visual Arts (AIVA).
Thanks to rapid advancements in precision medicine, oncologists are able to personalize cancer treatment based on a patient’s unique molecular structure.
FCS Director of Drug Development Manish R. Patel, MD, is an oral presenter of an abstract for cutting-edge treatment for prostate cancer at the AUA 2025 meeting.